The proliferative type of ICC accounts for 62% of ICC and is defined by activation of oncogenic signaling pathways, most notably through receptor tyrosine kinases (RTK) [32]. The gene discussed is NTRK1; the disease is intrahepatic cholangiocarcinoma.